Poll shows Americans fear second wave of infections
DES MOINES, Iowa — Strong concern about a second wave of coronavirus infections is reinforcing widespread opposition among Americans to reopening public places, a new poll finds, even as many state leaders step up efforts to return to life before the pandemic.
Yet support for public health restrictions imposed to control the virus’ spread is no longer overwhelming. It has been eroded over the past month by a widening partisan divide, with Democrats more cautious and Republicans less anxious as President Donald Trump urges states to “open up our country,” according to the new survey from The Associated Press-NORC Center for Public Affairs Research.
The poll finds 83% of Americans are at least somewhat concerned that lifting restrictions in their area will lead to additional infections, with 54% saying they are very or extremely concerned such steps will result in a spike of COVID-19 cases.
A solid majority of Americans support rigorous criteria for economic reopening that goes beyond wearing masks in public places and continued social distancing.
About 8 in 10 say it’s essential to reopening for people to return to self-quarantine if they are exposed to the virus. Roughly 6 in 10 also say having widespread testing for the coronavirus in their area is essential to re-establishing public activities, along with requiring people to keep 6 feet apart in most places and to wear face masks when they’re near others outside their homes.
Nearly as telling as the public’s appetite for rigorous precaution: Close to half say it is essential that a vaccine be available before public life resumes. A third say it’s important but not essential.
Taken together, the findings suggest that while some Americans are anxious to get back to business as usual, most don’t see the country returning anytime soon to what once was considered normal. Instead, Americans largely envision a protracted period of physical distancing, covered faces and intermittent quarantines ahead, perhaps until a vaccine is available.
The latest AP-NORC survey was conducted over this past weekend, before Monday’s news of positive results in a clinical trial of a potential vaccine.